Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
about
Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolveConcurrent therapy to enhance radiotherapeutic outcomes in glioblastomaHydrogen peroxide - production, fate and role in redox signaling of tumor cellsClinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?Selenoproteins in Tumorigenesis and Cancer Progression.
P2860
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Phase 1/2 trials of Temozolomi ...... me: final results of RTOG 0513
@nl
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@ast
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@en
type
label
Phase 1/2 trials of Temozolomi ...... me: final results of RTOG 0513
@nl
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@ast
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@en
prefLabel
Phase 1/2 trials of Temozolomi ...... me: final results of RTOG 0513
@nl
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@ast
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@en
P2093
P2860
P1476
Phase 1/2 trials of Temozolomi ...... e: final results of RTOG 0513.
@en
P2093
David G Brachman
Erin M Dunbar
H Ian Robins
Jason K Rockhill
Joseph A Bovi
Lynn S Ashby
Minhee Won
Samir Narayan
Stephanie L Pugh
Theresa A Thomas
P2860
P304
P356
10.1016/J.IJROBP.2014.12.050
P407
P577
2015-04-01T00:00:00Z